Clinical Trial Update: Intracavernous Injection of Botox 100 U for Treatment of PDE5Is Inconvenient Patients With ED [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on intracavernous injection of Botox 100 U for erectile dysfunction in patients inconvi... use of PDE5 inhibitors; Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Botox 100 U (onabotulinumtoxinA)

Snippet

Sponsor: Benha University | Conditions: Erectile Dysfunction | Phase 2, Phase 3 | Status: UNKNOWN